Di Giovanni C - Search Results

1

Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells.

Capasso A, Cerchia C, Di Giovanni C, Granato G, Albano F, Romano S, De Vendittis E, Ruocco MR, Lavecchia A. Capasso A, et al. Among authors: di giovanni c. Oncotarget. 2015 Nov 24;6(37):40202-22. doi: 10.18632/oncotarget.5473. Oncotarget. 2015. PMID: 26474275 Free PMC article.

2

Inhibitors of Cdc25 phosphatases as anticancer agents: a patent review.

Lavecchia A, Di Giovanni C, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. Expert Opin Ther Pat. 2010 Mar;20(3):405-25. doi: 10.1517/13543771003623232. Expert Opin Ther Pat. 2010. PMID: 20166845 Review.

3

Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.

Lavecchia A, Di Giovanni C, Pesapane A, Montuori N, Ragno P, Martucci NM, Masullo M, De Vendittis E, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. J Med Chem. 2012 May 10;55(9):4142-58. doi: 10.1021/jm201624h. Epub 2012 May 1. J Med Chem. 2012. PMID: 22524450

4

Discovery of a novel small molecule inhibitor targeting the frataxin/ubiquitin interaction via structure-based virtual screening and bioassays.

Lavecchia A, Di Giovanni C, Cerchia C, Russo A, Russo G, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. J Med Chem. 2013 Apr 11;56(7):2861-73. doi: 10.1021/jm3017199. Epub 2013 Mar 29. J Med Chem. 2013. PMID: 23506486

5

Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion.

Pesapane A, Di Giovanni C, Rossi FW, Alfano D, Formisano L, Ragno P, Selleri C, Montuori N, Lavecchia A. Pesapane A, et al. Among authors: di giovanni c. Oncotarget. 2015 Jul 20;6(20):18116-33. doi: 10.18632/oncotarget.4016. Oncotarget. 2015. PMID: 26062445 Free PMC article.

6

CDC25 phosphatase inhibitors: an update.

Lavecchia A, Di Giovanni C, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. Mini Rev Med Chem. 2012 Jan;12(1):62-73. doi: 10.2174/138955712798868940. Mini Rev Med Chem. 2012. PMID: 22070688 Review.

7

Virtual screening strategies in drug discovery: a critical review.

Lavecchia A, Di Giovanni C. Lavecchia A, et al. Among authors: di giovanni c. Curr Med Chem. 2013;20(23):2839-60. doi: 10.2174/09298673113209990001. Curr Med Chem. 2013. PMID: 23651302 Review.

8

Cdc25B phosphatase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.

Lavecchia A, Coluccia A, Di Giovanni C, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. Anticancer Agents Med Chem. 2008 Dec;8(8):843-56. doi: 10.2174/187152008786847783. Anticancer Agents Med Chem. 2008. PMID: 19075567 Review.

9

CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.

Lavecchia A, Di Giovanni C, Novellino E. Lavecchia A, et al. Among authors: di giovanni c. Curr Med Chem. 2009;16(15):1831-49. doi: 10.2174/092986709788186084. Curr Med Chem. 2009. PMID: 19442149 Review.

10

Discovery of new small molecules targeting the vitronectin-binding site of the urokinase receptor that block cancer cell invasion.

Rea VE, Lavecchia A, Di Giovanni C, Rossi FW, Gorrasi A, Pesapane A, de Paulis A, Ragno P, Montuori N. Rea VE, et al. Among authors: di giovanni c. Mol Cancer Ther. 2013 Aug;12(8):1402-16. doi: 10.1158/1535-7163.MCT-12-1249. Epub 2013 May 22. Mol Cancer Ther. 2013. PMID: 23699658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters